As COVID-19 spread through the U.S. in 2020, the death rates for heart disease and diabetes saw significant increases, according to data from the CDC's Mortality Dashboard.
Cardiology
Nearly 20% of people with sudden, unexplained cardiac death carry rare genetic variants, study finds
Among 413 people who died of sudden unexplained heart failure, nearly 1 in 5 carried rare genetic variants that likely raised their risk of sudden cardiac death, according to research findings published June 2 in JAMA Cardiology.
Valley View, a nonprofit health system in Glenwood Springs, Colo., is performing open heart surgeries through a new program, the organization said June 9.
Post-heart transplant survival among recipients aged 70 and older does not differ significantly from that of younger recipients, suggesting older age alone should not disqualify patients for the procedure, according to research findings published June 8 in Journal of the…
Timothy Swain, MD, cardiothoracic surgeon, and Martha Drake, DNP, nurse practitioner, have joined the team of heart specialists at Michigan City, Ind.-based Franciscan Physician Network Heart Center, reports community homepage What's New LaPorte?
Advertisement
After Medtronic announced it was pulling its Heartware Ventricular Assist Device System from the market June 3, Abbott said it has the supply and capacity to fill the gap and meet the demand for mechanical circulatory support devices.
Stan Holland, director of the cardiovascular service line at Harrisburg, Va.-based Rockingham Memorial Hospital, discussed big trends in cardiology and caregiver wellness during a recent episode of the Becker's Healthcare cardiology podcast.
Cardiologists at Detroit-based Henry Ford Hospital are the first in the nation and second worldwide to implant a circulatory support device meant to improve blood flow among patients with acute decompensated heart failure and declining kidney function, known as cardiorenal…
Medtronic will no longer sell and distribute its Heartware Ventricular Assist Device System due to numerous reports of patient harm and death linked to the device, the company said June 3.
After significant drops during earlier waves of the COVID-19 pandemic, emergency hospitalizations for heart attacks and suspected strokes have rebounded to pre-pandemic levels, according to research published June 2 in JAMA.